Guest guest Posted June 27, 2005 Report Share Posted June 27, 2005 " Zeus " <info UK government and trade associations support dossiers/ UK FSA Mon, 27 Jun 2005 04:12:26 +0100 UK government and trade associations support dossiers The UK's Health Food Manufacturers Association (HFMA) have pushed the UK government hard to promote dossiers - ANH wonders why? The ANH is concerned about the fact that the HFMA are promoting dossiers in their current form when they themselves are challenging, in parallel with the ANH, the legality of the EU Food Supplements Directive. This provides a very mixed message for the Regulators. Advocate General Geelhoed, in his Opinion released on 5 April considered the dossier system to be non-transparent and this contributed significantly to his view that the Directive was invalid under EU law, in its present state. Therefore by promoting dossiers (see Nutraingredients.com release below), the HFMA and the UK government are promoting a system that is potentially defective and invalid under EU law. The existing dossier system will contribute, in the view of the ANH, to even greater problems when the Directive is expanded to include nutrient groups other than vitamins and minerals, including plant extracts, phytonutrients, amino acids, essential fatty acids, fibre, etc. Furthermore, submission of a dossier on vitamins and minerals is no guarantee of approval by the European Food Safety Authority. The dossier system is strictly only a derogation, for approved substances, up until 31 December 2009. It is not a system that guarantees substances are added to the 'positive list'. The ANH argues that the framework for assessing safety of food supplements needs to be completely re-developed from the ground up. The existing system is seriously defective and dispropotionate. There is also no proper scientific rationale behind the separation of nutrient forms (Article 4) and dosages (Article 5) as in the present Directive, if the key criteria on selection of nutrients for trade in the European Union is to be safety. Safety, from a toxicological viewpoint, is a function of both the intrinsic properties of a given substance and its exposure i.e. dosage. These two aspects therefore need to be considered together. In the view of the ANH, the best way forward is to commission research by independent risk assessment scientists, with the purpose of developing a new regulatory framework that is both scientifically valid as well as being compatible with European law. ANH is close to being able to commission such work. UK releases funding to support more supplement dossiers (Source: http://www.nutraingredients.com/news/ng.asp?n=60728 & m=1NIE617 & c=siizoxouzpdntny) 17/06/2005 - The UK's food authority said this week that it will provide up to £20,000 (€30,000) to pay for external scientists to produce more dossiers for supplement ingredients not currently on the European directive's positive list, reports Dominique Patton. The Food Standards Agency (FSA) said it wanted to encourage further dossier submission, by giving derogation to all dossiers submitted in the UK or another member state, and supporting the scientific work, in order to protect consumer choice in the UK. The deal, largely negotiated by the Health Food Manufacturer's Association (HFMA), is expected to lead to between 50 and 80 new dossiers, in addition to the 29 already completed. Extensive dossiers of scientific and technical information are required to keep any ingredients not listed in the new European supplements directive on the market after the law enters into force on 1 August. UK trade groups estimate that more than 200 ingredients, currently used in popular vitamin and mineral supplements in the UK, have been omitted from the 2002 directive's 'positive' list of permitted ingredients. Only 29 dossiers have so far been submitted to FSA. A major barrier to their submission is cost, which can go up to €350,000 for the more complex materials, which have little readily available data. Under the new agreement, FSA will match funding by the HFMA to pay a team of scientists led by HFMA technical adviser Michael Evans. The group has already started work on the dossiers and submitted a further 33 last week. They are aiming to add a similar amount before the 12 July deadline. Coincidentally, this date will also decide the future of the directive itself. UK trade groups, anticipating serious damage by the law to their business, took the Commission to the European Court of Justice in January, alleging that it infringed basic principles of free trade. An initial opinion from the advocate general in April was in favour of rewriting the directive. The final judgement on 12 July is more likely to support the advocate general than go against his view but industry has continued working on dossiers to limit the risks of the directive going ahead. If the verdict is negative, maximising the number of UK derogations greatly reduces the number of products banned by the directive in the short-term. " We're very pleased with this. It's a sign of commitment by the FSA. I haven't heard of anything like this being done before by FSA, " HFMA director David Adams told NutraIngredients.com. The dossier process does not however guarantee an ingredient's permanent acceptance on the marketplace. The derogation lasts until 2009, when the European Food Safety Authority (EFSA) must decide on the ingredient's status. " It still leaves the longer-term issue of how and whether to fund the very extensive extra work that is likely to be required for dossiers to obtain final approval from EFSA, " explained Adams. FSA is not evaluating any of the dossiers it receives, but merely acting as a postbox to the Commission. " We are relying on available data and not creating any new data for these dossiers. As some are not particularly full, it is quite possible that EFSA will ask detailed questions that require further scientific work, " Adams explained. This process could be altered by the outcome of the courtcase. If the decision follows that of the judge's initial opinion, HFMA is hoping for both harmonisation and national exceptions to the law. " We and our lawyers have developed a straightforward change to the directive that would create the opportunity for national exceptions but still allow pan-EU harmonisation and we would hope to see such a change implemented by the EU, " said Adams. An assessment of the directive's impact by the FSA in 2002 suggested that reformulation would cost manufacturers up to £3,000 (€4,372) per product. Companies also face relabelling costs of between £300-£500 for all products to comply with new labelling requirements under the law. 17-Jun-05 __ UK Food Standards Agency recognises ANH's legal challenge in the European Courts of Justice Please find below a letter from the Food Standards Agency acknowledging the significance of the ANH Legal Challenge to the EU Food Supplements Directive Please find below a letter received today from the Food Standards Agency in the UK which demonstrates that legislators and the European Food Safety Authority (EFSA) have acknowledged the significance of ANH's legal challenge. However, it is essential that pressure is maintained given that very extensive dossiers to show the safety of plant extracts, phytonutrients, probiotics, amino acids, essential fatty acids, fibre and enzymes etc would be likely to create an even greater hurdle for leading-edge food supplements than the dossier system for vitamins and minerals. In addition ANH's work to ensure appropriate settings of maximum dosage levels, and proper scientific risk assessment is critical. Letter to the Alliance for Natural Health 23 June 2005 Reference: PROVISIONS FOR PROVIDING DEROGATION FOR VITAMINS AND MINERALS As you know, the resource recently provided by the Food Standards Agency has ensured that a number of dossiers have been given derogation and can remain on the market after 1 August. We nevertheless recognise that a large number of substances will still not be covered by dossiers and therefore will not be available for use in products after this date. In view of the short time between the ruling from the European Court of Justice and the date the Directive comes into effect, the Agency has agreed to give derogation in response to the provision of basic information. This information will then be forwarded to the European Commission and the European Food Safety Authority (EFSA). This will maintain consumer choice and ensure that as many substances as possible are submitted for evaluation by EFSA and allow products to remain on the market for the foreseeable future although companies may need to provide more information to EFSA in order for products to be marketed indefinitely. Information addressing the following points should be submitted to the Agency with a covering letter by 10 July to allow transmission to the Commission by its 12 July deadline. Contact name and address for company Name of substance Length of time available on the market Are you aware of any reports of adverse effects associated with these substances – if so please provide details I would be grateful if you could forward this information to your members. I have also written to the National Association of Health Food Stores, the Health Foods Manufacturers Association, the Council for Responsible Nutrition and the Proprietary Association of Great Britain. Yours sincerely Clair Baynton 24-Jun-05 forwarded by Zeus Information Service Alternative Views on Health www.zeusinfoservice.com All information, data and material contained, presented or provided herein is for general information purposes only and is not to be construed as reflecting the knowledge or opinion of Zeus Information Service. Subscribe Free/Un: info feel free to forward far and wide.... Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.